2003
DOI: 10.1016/s0168-3659(03)00133-0
|View full text |Cite
|
Sign up to set email alerts
|

Organosilicate-polymer drug delivery systems: controlled release and enhanced mechanical properties

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
85
1
1

Year Published

2006
2006
2018
2018

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 134 publications
(90 citation statements)
references
References 10 publications
3
85
1
1
Order By: Relevance
“…The scanning electron microscopy analysis of spray dried powders showed spherical microparticles with nanoparticles on their surfaces (Müller et al, 2000;Pohlmann et al, 2002;Raffin et al, 2003). In parallel, silica nano and microparticles have been described as drug controlled release carriers prepared by sol-gel processes (Kortesuo et al, 2002;Smirnova et al, 2003), porous hollow silica nanoparticles (Chen et al, 2004) or organosilicate-polymer drug delivery systems (Cypes et al, 2003). Furthermore, silica particles have been studied for the adsolubilization of drugs and other substances on their surfaces, employing cationic or nonionic surfactants (Cherkaoui et al, 1998;Cherkaoui et al, 2000), and for development of powders for inhalation (Kawashima et al, 1998) and nanoparticles for in vitro gene transfer (Kneuer et al, 2000;Sameti et al, 2003).…”
Section: Introductionmentioning
confidence: 99%
“…The scanning electron microscopy analysis of spray dried powders showed spherical microparticles with nanoparticles on their surfaces (Müller et al, 2000;Pohlmann et al, 2002;Raffin et al, 2003). In parallel, silica nano and microparticles have been described as drug controlled release carriers prepared by sol-gel processes (Kortesuo et al, 2002;Smirnova et al, 2003), porous hollow silica nanoparticles (Chen et al, 2004) or organosilicate-polymer drug delivery systems (Cypes et al, 2003). Furthermore, silica particles have been studied for the adsolubilization of drugs and other substances on their surfaces, employing cationic or nonionic surfactants (Cherkaoui et al, 1998;Cherkaoui et al, 2000), and for development of powders for inhalation (Kawashima et al, 1998) and nanoparticles for in vitro gene transfer (Kneuer et al, 2000;Sameti et al, 2003).…”
Section: Introductionmentioning
confidence: 99%
“…Figure 13 shows the influence of the initial STX amount incorporated in PAA/PMVK carrier on the dynamic release of STX at different media pHs at 23, 44 and 73h of release process, in which these periods correspond to the average intestinal transit times (AITT) [72,73]. From these data, it is revealed that the release dynamic of STX varies following a same trend for all durations and media pHs.…”
Section: Resultsmentioning
confidence: 99%
“…The value of the diffusion coefficient, D, can be calculated according to the following Equation (10). [59][60][61][62] where l is the thickness of the film and m t , m o , and t are as defined previously.…”
Section: Diffusion Behavior Of Fa Through Fahema Filmsmentioning
confidence: 99%
“…The influence of the total drug content grafted on PHEMA on the FA released is carried out at different pH media during 10 and 24 h of the release process which corresponds to the average intestinal transit time (AITT) [54][55][56][57][58][59][60][61][62][63][64][65] and the results obtained are gathered in Figure 12. As it can be seen from these curve profiles that at any pH medium and at any duration the variation of the FA released vs. the total FA content grafted has practically the same profiles, which dramatically decreased when the total FA grafted on PHEMA increased and reached a minimum at about 15 wt% of FA content, notably those at pH 5 and 7 during 24 h of the release process, except that at pH 1 in which the dynamic release continue to decrease slowly.…”
Section: Effect Of the Fa Content In Fahema Systemmentioning
confidence: 99%